Patent details
EP3784233 Title: METHODS FOR TREATING TESTICULAR AND OVARIAN ADRENAL REST TUMORS
Basic Information
- Publication number:
- EP3784233
- PCT Application Number:
- US2019029486
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP197931819
- PCT Publication Number:
- WO2019210266
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- METHODS FOR TREATING TESTICULAR AND OVARIAN ADRENAL REST TUMORS
- French Title of Invention:
- MÉTHODES DE TRAITEMENT DE TUMEURS DES VERTIGES SURRÉNALIENS DES TESTICULES ET DES OVAIRES
- German Title of Invention:
- VERFAHREN ZUR BEHANDLUNG VON HODEN-UND EIERSTOCK-NEBENNIERENTUMOREN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 24/06/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 03/07/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 05/06/2024
- Unitary Effect Registration Date:
- 03/07/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 26/04/2019
- Grant date:
- 05/06/2024
- EP Publication Date:
- 03/03/2021
- PCT Publication Date:
- 31/10/2019
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 05/06/2024
- EP B1 Publication Date:
- 05/06/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 26/04/2039
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 29/05/2024
- Name:
- Spruce Biosciences, Inc.
- Address:
- 611 Gateway Boulevard, Suite 740, South San Francisco, CA 94080, United States (US)
Inventor
1
- Name:
- GERBER, Hal
- Address:
- United States (US)
2
- Name:
- HOWERTON, Alexis
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201862663951 P
- Priority Date:
- 27/04/2018
- Priority Country:
- United States (US)
2
- Priority Number:
- 201962822815 P
- Priority Date:
- 23/03/2019
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/4162; A61K 31/505; A61K 31/519; C07D 231/54; C07D 233/70; C07D 247/02; A61K 9/20; A61P 35/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202423
- Publication date:
- 05/06/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202503
- Publication date:
- 15/01/2025
- Description:
- Opposition procedure started
3
- Issue number:
- 202429
- Publication date:
- 17/07/2024
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
4
- Issue number:
- 202429
- Publication date:
- 17/07/2024
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
5
- Issue number:
- 202431
- Publication date:
- 31/07/2024
- Description:
- Unitary Effect Request Receipt
6
- Issue number:
- 202432
- Publication date:
- 07/08/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|